Asthma Clinical Trial
Official title:
Effects of Patient-centred Asthma Education for GPs and Practice Nurses:Evaluating the Impact of Training in Self Regulation Skills on Patient Outcomes:a Randomised Controlled Trial
This study will address the key question of developing shared understanding and negotiating mutually acceptable outcomes between people with asthma and healthcare professionals by applying theoretical knowledge of self regulation and communication skills learning and practice to asthma consultations. This study will facilitate integration of best practice into normal care using the BTS/SIGN asthma guidelines as the basis for structured care. This intervention has been show to be effective in the US. We aim to show that it can be effective in the UK setting in a cluster randomised control trial. We aim to modify and evaluate the intervention in such a way that it can be easily offered across UK primary care settings, with the possibility of significant benefits for patients. The intervention is based on the principle of empowering patients to manage their condition themselves, is consistent with the aims of Asthma UK, and, for this reason, we believe that Asthma UK may wish to be associated with this project.
This study involves training GPs and nurses to recognize that patients differ in terms of
asthma characteristics, such as symptoms and triggers, as well as personal attributes and
lifestyles. The programme teaches professionals to work with patients to improve their
asthma management; this involves helping people with asthma to observe themselves and their
own actions, and learn from these, to support self-help behaviours, integrating these into
their daily routines. The programme emphasizes good communication skills and working in
partnership with patients, as well as up-dating doctors and nurses in current best practice
for treating asthma. It is based on a programme successfully developed with American office
based paediatricians, which resulted in greater parent satisfaction with asthma visits to
doctors, and better asthma symptom control for patients. We wish to modify this American
programme to make it more suitable for UK doctors, nurses and patients. We have also
included a component into the programme to identify what exactly is effective in terms of
how it impacts on clinician attitudes, beliefs and behaviour before delivering it more
widely. The success of the project is evaluated not only by testing whether it improves the
medical care and medical outcomes of patients of the health professionals taking part, but
also by measuring whether patients are more satisfied with their consultations for asthma if
their doctor or nurse has taken part in the programme. UK (http://www.sign.ac.uk/)
evidence-based guidelines recommend helping those with asthma to control their symptoms and
improve their quality of life through provision of education and individualised, written
action plans. Our aim is to carry out a prospective, cluster randomised trial in general
practices in Aberdeen and Glasgow, Scotland, to assess the impact of an educational
intervention targeted at training practice nurses and general practitioners (GPs) in
patient-centred asthma care; specifically in how to help patients develop asthma self
regulation skills. The intervention is modified from a programme successfully implemented
with American office based paediatricians, found to be effective in an US paediatric asthma
population in terms of clinical outcomes and parent satisfaction (1).
The hypothesis is that patients seen by doctors and nurses in primary care who have been
trained in developing patient self regulation skills will have better asthma-related quality
of life, control and clinical outcomes, and be more satisfied with the clinical
consultation, than a control group of patients attending doctors and nurses who have not
received training.
One nominated GP and one nominated practice nurse from eight intervention practices will
receive training modified from the Clark-Evans programme of asthma training. GPs and
practice nurses nominated by eight control practices will deliver care as usual during the
study.
Patients will be targeted for recruitment when they present with symptoms or signs relating
to poorly controlled asthma to the nominated GPs or Practice nurses. Questionnaire data will
be collected from a baseline cohort, until 20 datasets per practice (16) have accrued (320
in total). Questionnaire data will then be collected from 20 patients per practice
presenting in the same circumstances to the nominated GPs and Practice nurses in the
intervention practices (160 in total). Questionnaire data will also be collected from 20
patients per practice presenting in the same circumstances to the nominated GPs and Practice
nurses in the control practices, who will deliver care as usual (160 in total). The post
training cohorts (control and intervention) will have follow up questionnaires at 3 and 12
months after the index consultation. Routinely available data will be collected for all
patients with evidence of poorly controlled asthma before and after training. A total of 320
patients (160 to each arm) from a total of 16 practices (ie. 20 patients per practice) will
ensure 90% power in the baseline and post-intervention cohorts at the 5% significance level
(randomisation is by practice so this sample size calculation was inflated to correct for
the intracluster correlation coefficient (ICC)) .
The primary outcome measures will be the Mini AQLQ (2) and the Medical Interview
Satisfaction Scale (MISS-21) (3). Secondary measures will be: Patients' Perception of their
Involvement Questionnaire (4), the Asthma Control Questionnaire, (ACQ) (5). A theory of
planned behaviour questionnaire will be used to examine how specific components of the
training package influenced GP and practice nurse attitudes, behavioural intentions and
self-efficacy. This will identify how and why the training worked, and inform further
modifications of the programme to aid generalizability across UK settings.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|